Does treatment with drug-eluting stents reduce mortality rates compared to Coronary-Artery Bypass Grafting in patients with multivessel disease?
Patients with multivessel coronary disease
Drug-eluting stents
Coronary-Artery Bypass Grafting (CABG)
Mortality rateshard clinical
In patients with multivessel coronary disease, CABG remains superior to drug-eluting stents in reducing mortality, myocardial infarction, and the need for repeat revascularization.
For patients with multivessel disease, CABG continues to be associated with lower mortality rates than does treatment with drug-eluting stents and is also associated with lower rates of death or myocardial infarction and repeat revascularization.
Building similarity graph...
Analyzing shared references across papers
Loading...
Edward L. Hannan
Interventional Cardiology
Chuntao Wu
North China University of Science and Technology Affiliated Hospital
Gary Walford
Johns Hopkins University
New England Journal of Medicine
New York University
Duke Medical Center
Columbia University Irving Medical Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Hannan et al. (Wed,) studied this question.
synapsesocial.com/papers/69dff07eb28b234044e9be89 — DOI: https://doi.org/10.1056/nejmoa071804